MetLife Investment Advisors »

Mirati Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $63k 1.1k 58.75
2023-09-30 $39k 905 43.56
2023-06-30 $33k 903 36.13
2023-03-31 $34k 924 37.18
2022-12-31 $42k 922 45.31
2022-09-30 $62k 885 70.06
2022-06-30 $61k 906 67.13
2022-03-31 $197k 2.4k 82.22
2021-09-30 $23k 130 176.91
2021-03-31 $2.7M 16k 171.30
2020-12-31 $3.7M 17k 219.64
2020-09-30 $2.6M 16k 166.05
2020-06-30 $1.8M 16k 114.18
2020-03-31 $973k 13k 76.89
2019-12-31 $1.5M 12k 128.86
2019-09-30 $934k 12k 77.90
2019-06-30 $986k 9.6k 102.96
2019-03-31 $702k 9.6k 73.30
2018-12-31 $365k 8.6k 42.42
2018-09-30 $628k 13k 47.10
2018-06-30 $424k 8.6k 49.34